STRO-002
STRO-002-GM1
Phase 1 small_molecule completed
Quick answer
STRO-002 for Ovarian Cancer is a Phase 1 program (small_molecule) at SUTRO BIOPHARMA, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- SUTRO BIOPHARMA, INC.
- Indication
- Ovarian Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed